Mineralocorticoid receptor antagonist use in renal dialysis: will evidence from prospective randomized trials confirm the results from 'real-world' evidence?

被引：1
作者：
Rossignol, Patrick [1 ,2 ,3 ,4 ,6 ,7 ]
Pitt, Bertram [5 ]
机构：
[1] Univ Lorraine, Inserm, U1116, CHRU Nancy,Ctr Invest Clin Plurithemat 14 33, Nancy, France
[2] F CRIN INI CRCT Cardiovasc & Renal ClinicalTrialis, Nancy, France
[3] Princess Grace Hosp, Med & Nephrol Dialysis Dept, Monaco, Monaco
[4] Monaco Private Hemodialysis Ctr, Monaco, Monaco
[5] Univ Michigan, Sch Med, Ann Arbor, MI USA
[6] Univ Lorraine, Inserm, U1116, CHRU Nancy,Ctr Invest Clin Plurithematique 14 33, 4 Rue Morvan, F-54500 Vandoeuvre Les Nancy, France
[7] F CRIN INI CRCT Cardiovasc & Renal Clin Trialists, 4 Rue Morvan, F-54500 Vandoeuvre Les Nancy, France
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷 / 03期
关键词：
CHRONIC KIDNEY-DISEASE; SAFETY; HEMODIALYSIS; MANAGEMENT; EFFICACY;
D O I：
10.1002/ejhf.2804
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：361 / 363
页数：3
相关论文
共 16 条
[1]   Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis [J].
Agarwal, Rajiv ;
Filippatos, Gerasimos ;
Pitt, Bertram ;
Anker, Stefan D. ;
Rossing, Peter ;
Joseph, Amer ;
Kolkhof, Peter ;
Nowack, Christina ;
Gebel, Martin ;
Ruilope, Luis M. ;
Bakris, George L. .
EUROPEAN HEART JOURNAL, 2022, 43 (06) :474-+
[2]   Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial [J].
Agarwal, Rajiv ;
Rossignol, Patrick ;
Romero, Alain ;
Garza, Dahlia ;
Mayo, Martha R. ;
Warren, Suzette ;
Ma, Jia ;
White, William B. ;
Williams, Bryan .
LANCET, 2019, 394 (10208) :1540-1550
[3]   Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease BLOCK-CKD Trial [J].
Bakris, George ;
Yang, Y. Fred ;
Pitt, Bertram .
HYPERTENSION, 2020, 76 (01) :144-149
[4]   Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial [J].
Butler, Javed ;
Anker, Stefan D. ;
Siddiqi, Tariq Jamal ;
Coats, Andrew J. S. ;
Dorigotti, Fabio ;
Filippatos, Gerasimos ;
Friede, Tim ;
Goehring, Udo-Michael ;
Kosiborod, Mikhail N. ;
Lund, Lars H. ;
Metra, Marco ;
Quinn, Carol Moreno ;
Pina, Ileana L. ;
Pinto, Fausto J. ;
Rossignol, Patrick ;
Szecsody, Peter ;
Van der Meer, Peter ;
Weir, Matthew ;
Pitt, Bertram .
EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (01) :230-238
[5]   Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Kidney Failure Patients Treated with Dialysis A Systematic Review and Meta-Analysis [J].
Chen, Kuan-Ting ;
Kang, Yi-No ;
Lin, Yen-Chung ;
Tsai, I-Lin ;
Chang, Wei-Chiao ;
Fang, Te-Chao ;
Wu, Mai-Szu ;
Kao, Chih-Chin .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (06) :916-925
[6]   Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension [J].
Freeman, Mason W. W. ;
Halvorsen, Yuan-Di ;
Marshall, William ;
Pater, Mackenzie ;
Isaacsohn, Jon ;
Pearce, Catherine ;
Murphy, Brian ;
Alp, Nicholas ;
Srivastava, Ajay ;
Bhatt, Deepak L. L. ;
Brown, Morris J. J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (05) :395-405
[7]   The effects of mineralocorticoid receptor antagonists on cardiovascular outcomes in patients with end-stage renal disease and heart failure [J].
Lin, Donna Shu-Han ;
Lin, Fang-Ju ;
Lin, Yu-Sheng ;
Lee, Jen-Kuang ;
Lin, Yen-Hung .
EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (01) :98-107
[8]   Spironolactone Reduces Cardiovascular and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients [J].
Matsumoto, Yoshihiro ;
Mori, Yasuo ;
Kageyama, Shinji ;
Arihara, Kazuo ;
Sugiyama, Toshikazu ;
Ohmura, Hiromichi ;
Yakushigawa, Toru ;
Sugiyama, Hatsumi ;
Shimada, Yasushi ;
Nojima, Youichi ;
Shio, Nobuo .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (06) :529-536
[9]   Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease [J].
Ortiz, Alberto ;
Ferro, Charles J. ;
Balafa, Olga ;
Burnier, Michel ;
Ekart, Robert ;
Halimi, Jean-Michel ;
Kreutz, Reinhold ;
Mark, Patrick B. ;
Persu, Alexandre ;
Rossignol, Patrick ;
Ruilope, Luis M. ;
Schmieder, Roland E. ;
Valdivielso, Jose M. ;
Del Vecchio, Lucia ;
Zoccali, Carmine ;
Mallamaci, Francesca ;
Sarafidis, Pantelis .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (01) :10-25
[10]   Mineralocorticoid Receptor Antagonists in Patients With End-Stage Renal Disease on Chronic Hemodialysis [J].
Pitt, Bertram ;
Rossignol, Patrick .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (06) :537-538
12